Merck, Glenmark Antitrust MDL Must Go To Jury, Judge Says

By Dorothy Atkins · September 7, 2022, 5:02 PM EDT

A Virginia magistrate judge has recommended denying Merck and Glenmark's bids to end antitrust multidistrict litigation accusing the drugmakers of conspiring to delay generic competition for the branded cholesterol medication Zetia,...

To view the full article, register now.

Documents

Case Information

Case Title

In Re: Zetia (Ezetimibe) Antitrust Litigation

Case Number

2:18-md-02836

Court

Virginia Eastern

Nature of Suit

Anti-Trust

Date Filed

June 15, 2018